Á¦¸ñ
|
Á¦3ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ
|
ÀÛ¼ºÀÚ
|
KCFKOREA
|
ÀÛ¼ºÀÏÀÚ
|
2019-04-09
|
Á¦3ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ °³ÃÖ Àå¼Ò : »ñÆ÷·Î½ÃÁÖÃÖ : AHCC ¿¬±¸È¸ ÈÄ¿ø : ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷ÈÇÐ ÇÑ ÇØ µ¿¾È AHCC¸¦ ¿¬±¸ÇÏ°í ±× ¿¬±¸¼º°ú¸¦ ¹ßÇ¥ÇÏ´Â Á¦3Â÷ AHCC ¿¬±¸È¸°¡ ÀϺ» »ñÆ÷·Î¿¡¼ °³ÃֵǾú½À´Ï´Ù.AHCC ¿¬±¸È¸´Â ¿ÃÇØ·Î 3ȸ¸¦ ¸Â¾Ò½À´Ï´Ù.¿ÃÇØ °¿¬ Áß¿¡´Â °£¾Ï, °£¿°¿¡ ´ëÇÑ AHCCÀÇ È°¿ë¿¡ ´ëÇÑ °¿¬ÀÌ ´Ù¼ö º¸°íµÇ¾î°£Áúȯ¿¡ AHCCÀÇ »ç¿ë¿¡ °üÇÑ »õ·Î¿î ¹æÇâÁ¦½Ã°¡ µÈ ÀÚ¸®¿´½À´Ï´Ù. General Lecture ¡°Activation of macrophage by intraperitoneal treatment of AHCC¡± Yong-Qing Li, et al. £¨Hokkaido University, Japan£© ¡°Combination therapy of AHCC and chemotherapy significantrly reduce the metastasis of rat mammary adenocarcinoma¡± Kazuhiro Matsushita, et al. £¨Hokkaido University, Japan£© ¡°Protective effect of AHCC on carbon tetrachloride induced liver injury in mice -1¡± Buxiang Sun, et al. £¨Amino Up Chemical Co., Ltd., Japan£© ¡°Basic and clinical evaluation of AHCC immunotherapy¡± Akikuni Yagita, et al. £¨Kyorin University, Japan£© ¡°Case report of AHCC for hepatitis C¡± Mitsuaki Iwamoto, et al. £¨Hokusei Hospital, Japan£© ¡°Experience using AHCC for the resective case of hepatocarcinoma¡± Yasuo Kamiyama, et al. £¨Kansai Medical University, Japan£© ¡°Pitfall of immnotherapy¡± Takashi Ohmori, et al. £¨Usa Tyuou Naika Hospital, Japan£© ¡°Case report: Improvement of diabetes and active hepatitic C by AHCC¡± Shin-ichi Ozawa, et al. £¨Fujimoto Hospital, Japan£©
|
Á¶È¸¼ö
|
326
|
|